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The circadian system orchestrates the temporal organization of many aspects of physiology, 
including metabolism, in synchrony with the 24 hr rotation of the Earth. Like the metabolic 
system, the circadian system is a complex feedback network that involves interactions between 
the central nervous system and peripheral tissues. Emerging evidence suggests that circadian 
regulation is intimately linked to metabolic homeostasis and that dysregulation of circadian 
rhythms can contribute to disease. Conversely, metabolic signals also feed back into the circadian 
system, modulating circadian gene expression and behavior. Here, we review the relationship 
between the circadian and metabolic systems and the implications for cardiovascular disease, 
obesity, and diabetes.“It don’t mean a thing if it ain’t got that swing.”
—Edward Kennedy “Duke” Ellington (1899–1974)
What would music be without rhythm? So much in music 
depends upon timing, as do many aspects of our daily lives, 
including the rhythms of eating, fasting, sleep, and wakeful-
ness. These behaviors, although seemingly second nature, 
are now recognized to be governed by an intricate system of 
internal molecular clocks. These clocks coordinate biologi-
cal processes to maintain synchrony with the environmental 
cycles of light and nutrients. It has been known for many years 
that numerous aspects of metabolism exhibit daily rhythmicity, 
including many types of circulating and intracellular metabo-
lites, feeding-related hormones, and ingestive behaviors. 
Many of these rhythms are driven, at least in part, by circadian 
clocks. However, it has become clear that this is not a simple, 
linear relationship. Rather, metabolism and circadian clocks 
are tightly interlocked: clocks drive metabolic processes, and 
various metabolic parameters affect clocks, producing com-
plex feedback relationships (Figure 1).
The mechanism underlying circadian rhythmicity is com-
posed of a set of interlocking transcription/translation feed-
back loops that result in cascades of gene expression with 24 
hr periodicity (for a more detailed review of this mechanism, 
see Lowrey and Takahashi, 2004) (Figure 2). At the core of this 
mechanism in mammals is the heterodimeric transcription fac-
tor complex of CLOCK and BMAL1, which activates transcrip-
tion of the Period (Per) genes and Cryptochrome (Cry) genes 
via E-box enhancer elements in their promoters. The products 
of these genes interact to form complexes with each other. 
They also interact with other proteins such as casein kinase Iε. 
The PER/CRY repressive complex eventually translocates into 
the nucleus to inhibit CLOCK/BMAL1 transactivation activity, 728 Cell 134, September 5, 2008 ©2008 Elsevier Inc.resulting in the repression of the Per and Cry genes. Removal 
of the repressor complex, at least in part through ubiquitina-
tion and degradation by the proteasome (Siepka et al., 2007), 
eventually relieves repression, thereby allowing the negative 
feedback loop to start again.
Figure 1. The Sleep/Wake and Fasting/Feeding Cycles
Genetic and molecular evidence suggest that within both the central nervous 
system (CNS) and peripheral tissues, coregulation of the daily alteration be-
tween the sleep/wake and fasting/feeding cycles reflects coupling of both 
behavioral and metabolic pathways. Because the availability of food and the 
risk of predators are tied to the environmental cycle of light and darkness, 
these interlinked cycles may have provided selective advantages. Although 
this review focuses primarily on the interdependence of circadian and meta-
bolic systems, it is important to note that the circadian system also impacts 
sleep, the restriction of which is sufficient to lead to abnormalities in metabolic 
homeostasis.
Figure 2. Building Blocks of the Molecular 
Clock
The discovery of the core components of the cir-
cadian clock was first revealed through forward 
genetics showing that the clock is encoded by a 
transcription-translation feedback loop that os-
cillates with a periodicity of 24 hr in pacemaker 
neurons and peripheral cells. Subsequent analy-
ses have identified robust outputs of the clock 
on metabolic pathways in liver, fat, and muscle, 
suggesting convergence of circadian and meta-
bolic pathways at the transcriptional level. The 
core mammalian clock is comprised of the het-
erodimeric activators CLOCK and BMAL1 that 
activate transcription of the genes encoding the 
repressors PERIOD (PER) and CRYPTOCHROME 
(CRY). An interlocked regulatory loop directs al-
ternating activation and repression of BMAL1 
expression by the nuclear receptors RORα and 
REV-ERBα, respectively, via binding at the ROR 
enhancer elements (ROREs) in the BMAL1 pro-
moter. Several other metabolically active nuclear 
receptors and coactivators have been identified 
as modulators of BMAL and CLOCK, includ-
ing PPARγ and PGC1α. Physiological outputs 
of the clock within both neural and peripheral 
metabolic tissues may originate either directly 
through the core clock proteins (shaded circles) 
or through the rhythmic expression of transcription factors (dark blue) that are modulated by the clock. DBP, Albumin D-binding protein; TEF, thyrotroph 
embryonic factor; HLF, hepatocyte leukemia factor; HSF-1, heat shock factor 1; CREB, cyclic AMP response element-binding protein; ATF, activating 
transcription factor; CREM, cyclic adenosine monophosphate response element modulator.This core negative feedback loop is modulated by other 
interlocking feedback loops. The best characterized of these 
loops involves the orphan nuclear receptors REV-ERBα and 
RORα, which drive rhythmic Bmal1 expression. The Bmal1 
promoter contains ROR enhancer elements (ROREs) that can 
be bound by RORα and REV-ERBα: RORα activates transcrip-
tion, whereas REV-ERBα represses transcription. The Bmal1 
rhythmicity is driven by a rhythmic change in RORE occupancy 
by RORα and REV-ERBα. This alternating promoter occu-
pancy occurs because REV-ERBα levels are robustly rhyth-
mic, a result of direct transcriptional activation of the Rev-erbα 
gene by CLOCK/BMAL1 (Preitner et al., 2002).
This model of the molecular mechanism of the mamma-
lian circadian clock has been developed relatively recently—
the first mammalian clock genes were not cloned until 1997 
(Antoch et al., 1997; King et al., 1997; Sun et al., 1997; Tei et 
al., 1997). Thus, much of the early work in circadian rhythms 
in mammals focused on behavioral assays such as locomo-
tor activity. These studies found that the clock that controlled 
behavioral circadian rhythms was localized in the suprachias-
matic nucleus (SCN) in the hypothalamus (Ralph et al., 1990). It 
took the identification of core clock components that cycled at 
the mRNA level to provide “universal” markers for examination 
of rhythmicity in many tissues. The development of transgenic 
animals containing luciferase reporter constructs driven by the 
promoters of cycling clock genes was particularly instrumental 
in showing that circadian clocks existed in tissues throughout 
the body (Yamazaki et al., 2000; Yoo et al., 2004). The function 
of these peripheral clocks in most cases remains to be defined, 
but, as discussed below, it is likely that these clocks are impor-
tant for driving local rhythms that are physiologically relevant 
for each specific tissue. The system appears to be arranged 
in a hierarchical manner with the SCN acting as the “master pacemaker” in mammals. The SCN drives rhythmic behavior 
and coordinates the many peripheral clocks through as yet 
poorly defined humoral and neural signals as well as indirectly 
by modulating activity and food intake (Figure 3). This complex 
interplay between the CNS and periphery in driving circadian 
rhythms is reminiscent in many ways of the metabolic system. 
The peripheral metabolic tissues respond in various ways to 
metabolic signals, and the CNS coordinates these peripheral 
events through direct control and indirect means such as regu-
lation of food intake and energy expenditure.
Linking Circadian Rhythms to Metabolic Control
The pervasive circadian control of metabolism is exemplified 
by microarray studies that have examined gene expression 
profiles throughout the circadian cycle in the mammalian liver, 
skeletal muscle, and brown and white adipose tissue (Akhtar 
et al., 2002; Kita et al., 2002; McCarthy et al., 2007; Panda et 
al., 2002; Reddy et al., 2006; Storch et al., 2002; Ueda et al., 
2002; Zvonic et al., 2006). The numbers of genes judged to 
be rhythmic ranged from 3% to 20% in the different microar-
ray studies of gene expression profiles, suggesting that a large 
proportion of the transcriptomes in these tissues are under 
circadian control. Among the rhythmic genes identified, many 
have roles in biosynthetic and metabolic processes, including 
cholesterol and lipid metabolism, glycolysis and gluconeogen-
esis, oxidative phosphorylation, and detoxification pathways. 
Importantly, the rate-limiting enzymes in many of these path-
ways are under circadian control (Panda et al., 2002), suggest-
ing that the clock’s influence on these processes may be even 
broader than indicated by the numbers of rhythmic genes. The 
idea that these circadian oscillations in gene expression are 
physiologically meaningful is also supported by data showing 
that rhythmic genes in different tissues have varying degrees Cell 134, September 5, 2008 ©2008 Elsevier Inc. 729
of overlap, with different rhythmic gene 
patterns in the different tissues (McCa-
rthy et al., 2007; Panda et al., 2002; 
Storch et al., 2002; Ueda et al., 2002; 
Zvonic et al., 2006). This suggests that 
rhythmic gene expression is regulated in 
a tissue-specific manner, enabling each 
cell/tissue to appropriately carry out its 
unique function.
Similar results were also found in 
a comprehensive analysis of nuclear 
receptor mRNA profiles measured 
throughout the daily cycle in liver, skel-
etal muscle, and brown and white adi-
pose tissues (Yang et al., 2006). Of the 
49 nuclear receptor mRNAs analyzed, 
more than half were rhythmic, with some 
variation between the profiles in the dif-
ferent tissues. The broad rhythmicity of 
this class of transcription factors, which 
interact with dietary lipids and fat-sol-
uble hormones as ligands, suggests a 
rather direct link between nutrient-sens-
ing pathways and the circadian control 
of gene expression.
Considering these circadian gene 
expression patterns, it is difficult to infer 
whether the rhythmic patterns are driven 
directly by the core circadian clock mech-
anism or instead are driven indirectly by 
the rhythmic feeding profiles in the ani-
mals being tested (Figure 4). Because 
many metabolic genes are affected by 
the availability of nutrients, rhythmic 
feeding is likely to generate many such 
rhythms. In addition, rhythmic activity of animals affects body 
temperature, which again may contribute to driving rhythms in 
gene expression. This issue becomes even more complicated 
when one considers that the clocks located in many peripheral 
tissues such as the liver are rapidly entrained to food avail-
ability. Therefore, many possible signals may control rhythmic 
gene expression in the liver, including the central SCN clock, 
the mysterious “food-entrainable oscillator” (see below) in the 
brain (through some type of systemic signal), the local endog-
enous liver clock (which is coupled to the SCN clock), or food 
availability (either through signals from the food or through 
food entrainment of the liver clock).
To address such issues, a conditional transgenic mouse has 
been generated in which the circadian clock can be reversibly 
and specifically disabled only in the liver, keeping the rest of the 
circadian system intact (Kornmann et al., 2007). Tetracycline-
responsive, hepatocyte-specific overexpression of Rev-erbα 
in these mice causes constitutive repression of Bmal1 tran-
scription when the tetracycline analog doxycycline is absent, 
resulting in the loss of clock function. Normal Bmal1 expres-
sion and normal hepatic circadian clock function is restored by 
feeding the mice doxycycline. Microarray analysis of the livers 
of the doxycycline-fed mice revealed 351 circadian transcripts, 
with significant overlap with the previ-
ous liver microarray data sets. However, 
after removal of doxycycline from the 
food, the great majority of these rhyth-
mic genes no longer cycled in the liver, 
indicating that these genes are normally 
driven by the local liver clock and not by 
rhythmic systemic signals. Interestingly, 
31 genes were still observed to have 
robust circadian patterns of expression 
in the absence of doxycycline, suggest-
ing that this small subset of rhythmic liver 
genes is driven by some systemic signal 
independent of the liver clock. Thus, the 
control of metabolically relevant hepatic 
gene expression is complex, most likely 
responding to both external and cell-
autonomous signals to maintain appro-
priate temporal coordination of these 
metabolic pathways.
Food Can Entrain Circadian Clocks
The circadian/metabolic relationship is 
complicated by the fact that many tis-
sues and cell types contribute to the 
metabolic state. These tissues and cell 
types all contain endogenous circadian 
oscillators that communicate with each 
other in ways that are not well under-
stood. With regard to the circadian sys-
tem, the clock in the hypothalamic SCN 
is thought to be the “master clock” and 
is entrained by an external cue (zeitge-
ber): light from the eyes via the retino-
hypothalamic tract. This clock drives 
behavioral rhythms such as that of locomotor activity and 
coordinates the many peripheral clocks so that they maintain 
proper phase relationships with each other. It is now known 
that peripheral clocks can themselves also be entrained by 
various stimuli, with feeding being a dominant zeitgeber for 
many. In rodents that are given a restricted food (RF) paradigm 
where food is only available for a few hours during the day (a 
time when nocturnal rodents do not normally eat), the phase of 
many peripheral clocks shift by as much as 180° within about 
a week (Damiola et al., 2000; Stokkan et al., 2001). The liver 
clock entrains particularly rapidly to food availability, with large 
phase shifts within 2 days of an altered feeding schedule.
An interesting example of food’s effect on the liver periph-
eral clock comes from studies of the common vole Microtus 
arvalis, which normally has an ultradian pattern of activity with 
short bouts of feeding every 2–3 hr (van der Veen et al., 2006). 
These animals have circadian rhythms of gene expression in 
their SCN but not in their livers. However, if the voles are given 
food on a circadian time schedule, or if their activity becomes 
circadian (this happens when they are given a running wheel), 
their livers now exhibit circadian rhythms of gene expression. 
Mouse livers do not show this flexibility; if a mouse is given ult-
radian exposure to food, their livers remain rhythmic, although 
Figure 3. Central Pacemaker and Peripheral 
Clocks
The master pacemaker encoding the mamma-
lian clock resides within the SCN, although clock 
genes are also expressed in other regions of the 
brain and in most peripheral tissues. Emerging evi-
dence suggests that peripheral tissue clocks are 
synchronized through humoral, nutrient, and auto-
nomic wiring and that the cell-autonomous func-
tion of the clock is important in pathways involved 
in fuel storage and consumption. A hierarchical 
model indicates that all peripheral clocks are sub-
ordinate to the SCN. However, more recent work 
suggests that peripheral clocks play a broader role 
than previously realized in health and disease.730 Cell 134, September 5, 2008 ©2008 Elsevier Inc.
Figure 4. External Cues and Clock Outputs
The predominant external cue (zeitgeber) of the 
SCN clock is light. Clocks in peripheral tissues 
such as the liver also can be entrained by food. 
Nutrient and hormonal cues may also affect the 
period and phase characteristics of the master 
clock neurons, although little is known about how 
metabolic signals are communicated to the SCN. 
Outputs of both the SCN and peripheral clocks im-
pact behavioral and metabolic responses such as 
feeding, sleep-wakefulness, hormone secretion, 
and metabolic homeostasis. Figure adapted from 
Ramsey et al., 2007.the amplitude is somewhat dampened. These findings suggest 
that the rhythmicity of the liver is important for proper meta-
bolic function and that the voles have evolved a system to allow 
them to normally suppress the circadian aspect of liver func-
tion to adapt to their ultradian pattern of food intake.
What are the signals that arise from feeding that entrain the 
liver clock and other peripheral oscillators? They could be food 
itself, food-induced metabolites, or hormones whose secre-
tion is controlled by feeding or its absence. The mechanisms 
involved in the regulation of hepatic circadian oscillators are not 
yet fully understood, but several observations provide some 
insights into how this system may work. In cultured cell assays, 
many types of stimuli can induce or reset circadian clocks 
through regulation of clock gene expression (Balsalobre et al., 
1998, 2000a, 2000b). These factors include forskolin, phorbol 
esters, glucose, and glucocorticoids, indicating that activation 
of many common signaling pathways can converge to influence 
the circadian clock. For example, in Rat-1 fibroblast cultures, 
insulin causes an acute induction of Per1 mRNA production 
(Balsalobre et al., 2000b). Addition of a glucose bolus to the cul-
ture medium causes a downregulation of Per1 and Per2 mRNA 
levels and induces rhythmic gene expression patterns (Hirota 
et al., 2002). In this culture system, the downregulation of Per 
expression by glucose appears to be indirect (it is blocked by 
inhibition of transcription or translation) and seems to depend 
on glucose metabolism rather than glucose itself. Interestingly, 
it was recently reported that leptin causes upregulation of Per2 
and Clock gene expression in mouse osteoblasts, which have 
endogenous circadian clocks (Fu et al., 2005). Another example 
of clock regulation can be found in flies where the metabolic 
transcription factor FOXO has also been shown to modulate 
expression of clock genes and locomotor activity behavior 
(Zheng et al., 2007). Thus, multiple signals may be involved in the 
entrainment of clocks, including nutrients (sterols, lipids, and/
or carbohydrates), humoral signals (insulin, glucocorticoid, and 
perhaps incretin), and possibly even signals from vagal efferents 
that travel from autonomic centers to the liver (Cailotto et al., 
2008; Kalsbeek et al., 2004; Pocai et al., 2005).
Nutrient Signaling and Circadian Components
Many transcription factors that are known to respond to food 
or metabolites, such as nuclear receptors, also regulate com-
ponents of the circadian clock. As mentioned above, a recent 
comprehensive survey of nuclear receptor mRNA profiles in several metabolic tissues in mice revealed that more than half 
of the known nuclear receptors exhibit rhythmic mRNA expres-
sion profiles (Yang et al., 2006). These receptors, which sense 
various lipids, vitamins, and fat-soluble hormones, are known 
mediators of metabolism. Direct links between some of these 
rhythmic nuclear receptors and the core clock components 
have been demonstrated. Therefore, these nuclear receptors 
may be part of the pathway by which food can entrain the liver 
clock (Ramsey et al., 2007).
The orphan nuclear receptors RORα and REV-ERBα are 
themselves considered part of the clock mechanism and con-
tribute to an interlocking feedback loop that controls Bmal1 
transcription (Akashi and Takumi, 2005; Preitner et al., 2002; 
Sato et al., 2004). Interestingly, a critical role has recently been 
demonstrated for the peroxisome proliferator-activated recep-
tor (PPAR) nuclear receptor coactivator PGC-1α in circadian 
regulation (Liu et al., 2007). PGC-1α is a not a nuclear receptor 
itself but is a transcriptional coactivator that regulates nuclear 
receptor activity and is a regulator of genes important in oxi-
dative phosphorylation. PGC-1α stimulates Bmal1 expression 
through coactivation of ROR proteins. Liver-specific knock-
down of PGC-1α results in arrhythmicity, suggesting that this 
protein is required for normal clock function in this tissue. This 
protein is also of particular interest because it is inducible—
sensitive to a variety of environmental signals including nutri-
tional status, activity, and temperature—and is thought to reg-
ulate adaptive energy metabolism in multiple tissues (Leone et 
al., 2005; Lin et al., 2005). PGC-1α therefore may be a key com-
ponent that couples metabolic signals with clock function.
Other genes have been implicated in clock regulation. For 
example, Bmal1 is also transcriptionally regulated by the 
nuclear receptor PPARα, a key regulator of lipid metabolism 
(Canaple et al., 2006; Inoue et al., 2005). The glucocorticoid 
receptor has also been linked to the clock mechanism by the 
demonstration that glucocorticoids acutely induce Per1 in cell 
culture and can reset peripheral clocks in vivo (Balsalobre et 
al., 2000a; Reddy et al., 2007). In addition, in vascular tissue, 
RARα and RXRα have been shown to bind directly to CLOCK 
and the closely related NPAS2 (MOP4) protein in a hormone-
dependent manner, causing inhibition of CLOCK(NPAS2)/
BMAl1 activity (McNamara et al., 2001). Two recent studies 
raise interest in the role of the histone deacetylase SIRT1 in the 
integration of circadian and metabolic transcription networks 
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of the yeast Sir2 gene, a key factor in the longevity response 
to caloric restriction. SIRT1 has now been shown to interact 
directly with CLOCK and to deacetylate BMAL1 and PER2. 
Further studies will be necessary to delineate the physiologi-
cal intersection between these sirtuin proteins and circadian 
pathways and the potential implications for the coordination of 
feeding, activity, and metabolic homeostasis.
Another possibility that has not been well studied is that CLOCK, 
NPAS2, BMAL1, or the PERs may themselves act directly as sen-
sors for some feeding related signal. These proteins all contain 
PAS domains, an ancient sensory domain conserved throughout 
all kingdoms (reviewed in Gu et al., 2000; Kewley et al., 2004). PAS 
domains detect redox state, hypoglycemia, oxygen balance, and 
xenobiotic metabolism. Signals are transduced by PAS domains 
to the rest of the protein to induce changes in the functional state 
of the protein. Do these PAS-containing clock proteins have the 
ability to sense their environment and adjust their transcriptional 
activity accordingly? There are two interesting observations sug-
gesting that this may be the case.
The first example comes from experiments suggesting that 
cellular redox status is capable of altering CLOCK/BMAL1 and 
NPAS2/BMAL1 activity (Rutter et al., 2001). The reduced forms 
of the nicotinamide adenine dinucleotide cofactors, NADH and 
NADPH, were shown to stimulate the DNA-binding activity of 
these clock protein heterodimers, whereas the oxidized cofac-
tors inhibited DNA-binding activity. The conversion from active 
to inactive forms of CLOCK/BMAL1 (or NPAS2/BMAL1) occurs 
over a very narrow range of reduced to oxidized NAD ratios, 
making this a very sensitive switch. Therefore, changes in feed-
ing that alter cellular redox status could use such a mechanism 
to rapidly affect circadian clock activity. The in vivo importance 
of this mechanism as part of the food-entrainment pathway still 
remains to be directly demonstrated. In agreement with this 
model for regulating circadian clock activity, addition of lactate 
(which should increase the amount of reduced NAD) to neuro-
blastoma cells does cause NPAS2/BMAL1 activation (Rutter et 
al., 2001). However, the addition of pyruvate (which should also 
increase the reduced form of NAD) to Rat-1 fibroblasts does 
not increase the relative levels of Per1 or Per2 (direct targets of 
CLOCK/BMAL1 and NPAS2/BMAL1) (Hirota et al., 2002). Clearly, 
additional experiments are needed to determine whether redox 
status is an important aspect of circadian regulation by food.
In the second example, NPAS2 was demonstrated to bind 
to heme and may use this cofactor as a gas sensor (Dioum et 
al., 2002). In the heme-bound form, the DNA-binding activity 
of NPAS2 was inhibited by carbon monoxide (CO) in a dose-
dependent manner. This effect was distinct from the redox-
sensing regulation described above, which does not require 
bound heme. The physiological role for CO sensing as a clock 
input is unclear, but NPAS2 is known to be important for regulat-
ing expression of the rate-limiting enzyme for heme biosynthesis 
(aminolevulinic acid synthase; ALAS). This NPAS2 function may 
form a feedback loop that communicates the status of heme 
metabolism to the clock mechanism (Dioum et al., 2002; Kaasik 
and Lee, 2004). Interestingly, recent studies of Rev-ERBα have 
suggested that heme is an endogenous ligand, raising the pos-
sibility that heme may play a central role in coordinating circa-
dian function (Raghuram et al., 2007; Yin et al., 2007).732 Cell 134, September 5, 2008 ©2008 Elsevier Inc.Nutrient Signals and SCN Oscillators
Feeding signals entrain peripheral clocks with great efficacy, 
whereas the central SCN clock appears to be largely refractory 
to these signals (Damiola et al., 2000; Stokkan et al., 2001). How-
ever, there is evidence that the SCN can receive and respond to 
signals from feeding under at least some conditions.
In cases where timed feeding is also coupled with caloric 
restriction, effects on the rat SCN can be observed by phase 
shifts in locomotor activity, body temperature, and mela-
tonin rhythms (Challet et al., 1997). Entrainment to light-dark 
cycles is also altered (as measured both in activity rhythms 
and molecular rhythms in the SCN) (Mendoza et al., 2005b). 
In addition, light effects on the SCN are altered during times 
of low glucose availability (Challet et al., 1999). The rat SCN 
can also entrain to regular scheduled feeding (without caloric 
restriction), but this occurs much more slowly, taking nearly 
12 weeks to reach stable entrainment (as compared to the 3 
weeks required for rats under caloric restriction conditions) 
(Castillo et al., 2004). The reward aspects of food seem to be 
important in SCN entrainment, since rat SCNs can entrain to 
rhythmic palatable diet exposure on a background of constant 
feeding (ad lib) of regular diet in constant dark conditions (Men-
doza et al., 2005a). Finally, under conditions of constant light 
that cause the rat circadian rhythms to become arrhythmic, 
restricted feeding was capable of rescuing both locomotor 
activity rhythms and Per2 mRNA rhythms in the SCN (Lamont 
et al., 2005). Similar effects of restricted feeding on locomotor 
activity were previously also observed in hamsters maintained 
in constant light (Mistlberger, 1993).
Very little is known about how metabolic signals communi-
cate with the SCN. The nature of the signals is unknown, and it 
is not clear whether this is a direct or indirect regulation. Recep-
tors for leptin and ghrelin are present on SCN cells (Guan et al., 
1997; Yi et al., 2006; Zigman et al., 2006), so it is possible that 
these important metabolic peptides signal directly to these 
neurons. Indeed, administration of ghrelin to SCN slices or 
SCN explants in vitro caused phase shifts in Per2::luc reporter 
gene expression (Yannielli et al., 2007). However, administra-
tion of ghrelin to wild-type mice only caused phase shifts after 
30 hr of food deprivation, whereas intraperitoneal injection of 
ghrelin did not cause phase shifts in ad lib fed wild-type mice.
Neuropeptide Y (NPY) is a potent appetite transducer, and 
its secretion exhibits both ultradian and circadian rhythms. The 
relative levels of anorexigenic (leptin) and orexigenic (ghrelin) hor-
mones participate with the circadian clock in the hypothalamus in 
the coordination of the temporal patterns of NPY secretion. Dur-
ing restricted feeding paradigms, the daily pattern of NPY shifts 
along with the locomotor activity to anticipate the food availability 
(reviewed in Kalra and Kalra, 2004; Sindelar et al., 2005). However, 
in addition to being an “output” of the SCN clock, NPY also acts 
as an “input” to the SCN, involved in communicating nonphotic 
signals (reviewed in Yannielli and Harrington, 2004). In addition, 
both histaminergic and serotonergic signaling pathways that 
influence feeding and energy metabolism in the hypothalamus 
have been shown to modulate both SCN oscillations and sleep 
(Challet, 2007; Masaki et al., 2004). Therefore, these signaling sys-
tems appear to be involved in some sort of feedback loop to link 
feeding and metabolic state to the SCN.
A Food-Entrainable Oscillator
Understanding of the effects of food on the circadian system is 
complicated by the presence of another somewhat mysterious 
oscillator, the food-entrainable oscillator (FEO). This oscillator 
controls circadian rhythms of food-anticipatory behavior and, 
as its name suggests, is entrainable by food. When rodents 
are maintained on a restricted feeding regimen (for example, 
food is available for only a few hours during the middle of the 
day), within a few days they show increased activity and other 
behavioral changes shortly before the time that food becomes 
available. This rhythmic anticipatory activity has the hallmarks 
of bona fide circadian rhythms. Namely, the rhythms are main-
tained for several days of total food deprivation (i.e., they “free 
run” in constant conditions), they show phase-dependent 
phase shifts with transients after a shift in mealtime, and they 
are subject to limits of entrainment (for example, rats can only 
entrain to food cycles between 22 and 31 hr in length) (reviewed 
in Stephan, 2002). Despite these similarities to the SCN oscil-
lator, the FEO is anatomically distinct, because SCN lesions 
do not abolish the rhythmic food-anticipatory behavior. The 
anatomical location of the FEO is still not clear. Multiple lesion 
studies (ablation of the adrenals, hypothalamic structures, hip-
pocampus, amygdala, and nucleus accumbens, among oth-
ers) have failed to abolish this activity.
Although some consideration has been given to the idea that 
the FEO might reside within the digestive system itself, most 
studies point to a CNS location (Stephan, 2002). Recently, the 
dorsal medial hypothalamic (DMH) nucleus has received much 
attention as a possible oscillator site because of observations 
from two independent lines of experimentation. Mice lacking 
a functional Per2 gene (but not those lacking Per1) lose food-
anticipatory activity rhythms, suggesting that Per2 is a critical 
component of the FEO system (Feillet et al., 2006). Examina-
tion of Per2 expression throughout the brain revealed a robust 
rhythm in the DMH only when mice were entrained to restricted 
feeding conditions (Mieda et al., 2006). Furthermore, the DMH 
rhythm of Per2 persisted through 2 days of total food depri-
vation. Recent neurotoxic DMH lesions resulted in significant 
losses of food-anticipatory rhythms (as measured by general 
cage activity, sleep, and body temperature), also supporting 
DMH as the location for the FEO (Gooley et al., 2006). However, 
robust food-anticipatory rhythms were maintained in DMH-
lesioned animals in an independent study that examined a dif-
ferent behavioral readout (food bin approaches) (Landry et al., 
2007). The difficulty in conclusively identifying the location of 
the FEO has raised the possibility that the FEO may not reside 
in a single structure but may rather be distributed among many 
sites (Davidson, 2006).
Effects of Circadian Control on Metabolism
In view of the fact that metabolic networks are under exten-
sive circadian control at the levels of transcription, translation, 
and posttranslational mediated signaling, does the integration 
of circadian and metabolic cycles confer adaptive advantage 
and optimize energy utilization? Answers to this question have 
begun to emerge from studies in Cyanobacteria and the plant 
Arabidopsis thaliana. Observations in these model organisms 
indicate that synchrony of endogenous circadian period length with the environment may play a direct role in survival and opti-
mize functions ranging from photosynthesis to reproduction 
(Dodd et al., 2005; Ouyang et al., 1998). Cyanobacteria strains 
with circadian periods similar to that of the light-dark cycle had 
a higher relative fitness than those with periods different from 
the environmental light cycle. Likewise, plants in which inter-
nal period length is aligned with the external light cycle display 
improved carbon fixation, growth, and reproduction. Those 
plants in which period length is discordant with the light cycle 
display reduced fertility and longevity. Interestingly, although 
circadian clocks have not been identified in yeast, these organ-
isms exhibit robust metabolic cycles when cultured in nutrient-
poor conditions (Chen et al., 2007). The periodic cycles of gly-
colysis and respiration are closely coupled to the replicative 
phase of the cell cycle. Intriguingly, disruption of the synchrony 
of these cycles resulted in an increased rate of spontaneous 
DNA mutation. Together, these studies suggest that rhythmic 
partitioning of metabolic processes can enhance survival by 
coupling the cell division cycle with cycles of energy storage 
and utilization. The availability of mutant mice with different 
circadian periods now provides the opportunity to formally 
test the concept that circadian “resonance” (i.e., synchrony 
between the external light-dark cycle and the internal period) is 
important in metabolic health and energy balance.
Physiological Roles of Clock Genes
Analysis of mammals with genetic lesions that disrupt circadian 
rhythms has recently provided insight into the role of several of 
the major circadian clock genes in physiology. Homozygous 
Clock mutant mice of the C57BL/6J genetic background have 
severe alterations in energy balance, with a phenotype with 
many characteristics of metabolic syndrome, including obesity, 
hyperlipidemia, hepatic steatosis, high circulating glucose, and 
low circulating insulin (Turek et al., 2005). The feeding rhythm in 
these mice is dampened, with increased food intake during the 
day, resulting in significantly increased overall food intake. It is 
likely that this phenotype results, at least in part, from altered 
rhythms of neuropeptides in the hypothalamus—ghrelin, CART, 
and orexin are all expressed at constitutively low levels in the 
Clock homozygous mutant mice (Turek et al., 2005). Whether 
loss of clock function in the peripheral tissues contributes to 
this metabolic phenotype still remains to be seen. Interestingly, 
a lean phenotype is observed in Clock mutant mice outbred 
onto an ICR genetic background. However, this phenotype is 
caused by impaired lipid absorption in animals with an ICR 
genetic background (Oishi et al., 2006).
Circadian Clock Function in the Periphery
An important metabolic role for circadian clock function in 
the periphery has also been observed in other genetic mod-
els. For example, alterations in lipid and glucose homeosta-
sis occur with mutations in clock-related genes, such as the 
Nocturnin knockout mice. Although the Nocturnin gene is 
not itself part of the central clock mechanism, it is involved 
in posttranscriptional regulation of rhythmic gene expression 
(Baggs and Green, 2003; Garbarino-Pico et al., 2007). Noc-
turnin−/− mice have normal feeding behavior as well as normal 
food intake and activity levels. However, they remain lean on 
a high-fat diet. This is likely due to changes in lipid uptake or Cell 134, September 5, 2008 ©2008 Elsevier Inc. 733
utilization because these mice exhibit a loss of rhythmicity in 
genes important for these lipid pathways (Green et al., 2007). 
The Nocturnin−/− mice also have changes in glucose tolerance 
and improved whole-body insulin sensitivity.
Mice lacking the Bmal1 gene also have altered gluconeo-
genesis and improved whole-body insulin sensitivity (Ramsey 
et al., 2007; Rudic et al., 2004), suggesting clock control of 
these pathways. Furthermore, loss of Bmal1 in mouse embry-
onic fibroblasts results in the failure of these cells to differen-
tiate into adipocytes. The overexpression of BMAL1 results 
in induction of several genes involved in lipogenesis and 
increased lipid synthesis, suggesting that the circadian clock 
may also be important in proper adipocyte function (Shimba et 
al., 2005). However, the pleiotropic functions of BMAL1 make 
assessment of the global knockout phenotype particularly 
difficult since these animals become cachectic with age and 
develop both arthritic and myopathic complications (Kondra-
tov et al., 2006).
Mutation in another central clock gene, Per2, results in 
increased bone density in mice (Fu et al., 2005). Histomorpho-
metric analyses showed that Per2 null mice have an increased 
ratio of osteoblast to osteoclast activity, in addition to altered 
expression of Cyclin D1 and c-Myc. These pathways are reg-
ulated by leptin, and it appears that Per2 may play a role in 
mediating the leptin-dependent sympathetic regulation of 
bone formation. Since bone and adipose tissue share a com-
mon ontogeny, it is possible that these findings may also have 
implications for adipogenesis (Gimble et al., 2006). The Per2 
gene has also been implicated in cell cycle regulation in thymo-
cytes (Fu et al., 2002). Per2 null mice that have been irradiated 
with gamma radiation are more prone to tumor development, 
suggesting that Per2 functions as a tumor suppressor in these 
cells.
Clock Gene Effects on Metabolic Tissues
Several studies have also suggested a link between circadian 
clock genes and cell survival that may have an important effect 
on metabolic tissues. For example, there is increased sensitiv-
ity of Clock mutant mice to either cyclophosphamide or partial 
hepatectomy (Gorbacheva et al., 2005; Matsuo et al., 2003). 
Moreover, both Per1 mutant and Clock mutant animals dis-
play reduced expression of c-Myc, cyclin D1, and Wee-1, three 
cell cycle genes that exhibit pronounced circadian patterns 
of expression. CLOCK/BMAL1 may also impact cell growth, 
in part through direct effects on chromatin remodeling, or by 
influencing the generation of reactive oxygen species (ROS) 
(Doi et al., 2006; Kondratov et al., 2007).
How might molecular clock gene function influence the 
production of ROS? Studies of the clock disruption in myo-
cardium have begun to shed light on the mechanism of ROS 
generation and its contribution to cardiovascular dysfunction. 
Under normal growth conditions in myocardial cells, circadian 
clock expression influences the selection of fuel source and 
the balance between β-oxidation and glycolysis (Durgan et al., 
2006). Increased β-oxidation, which occurs after clock gene 
disruption in myocardium, contributes to increased production 
of ROS. Since altered circadian clock function may also limit 
the availability of glutathione, clock function may be impor-
tant in ROS inactivation (Kondratov et al., 2006). Interestingly, 734 Cell 134, September 5, 2008 ©2008 Elsevier Inc.recent work in Foxo mutant flies has suggested a tie between 
the generation of ROS and the regulation of the master neural 
pacemaker. Specifically, flies deficient in the FOXO transcrip-
tion factor display increased oxidative stress after exposure 
to paraquat and altered circadian locomotor activity patterns 
(Zheng et al., 2007). Since the mammalian ortholog of the fly 
FOXO (Foxo-1) is an essential regulator of insulin signaling in 
liver and other metabolic tissues (Matsumoto et al., 2006), it will 
be important to identify upstream factors linking circadian and 
metabolic cycles. Investigation into the convergence of insu-
lin signaling pathways with circadian systems may ultimately 
provide insight into the role of clock in β-oxidation and insulin 
resistance (Boudina et al., 2007).
Emerging evidence indicates that clock gene function also 
plays a crucial role in many other metabolic tissues (Young, 
2006). For example, clocks within skeletal muscle may 
affect alternation between glycolysis and β-oxidation. Clock 
expression may also be important in adipogenesis (a pro-
cess that also affects insulin sensitivity), as well as impact 
both adrenal and pancreatic physiology. Moreover, clock 
gene function has been shown to influence catecholamines 
within the adrenal medulla; circadian function at the level of 
both brain and peripheral organs may influence the counter-
regulatory response to hypoglycemia (Bartness et al., 2001; 
Oster et al., 2006). These wide-ranging phenotypes of clock 
gene disruption may reflect physiological problems at the 
tissue level, or it may be that clock dysfunction alters the 
phase relationship among multiple peripheral metabolic 
tissue clocks, thereby causing disruption of overall inter-
nal circadian resonance. These studies beg the question 
of what precisely causes the metabolic phenotypes that 
occur in many of the circadian cycle mutant mice. Are the 
phenotypes due to a loss of circadian function within spe-
cific metabolically relevant tissues, or are they the result of 
certain metabolic tissues being prone to circadian-misalign-
ment-induced dysfunction? In addition, it will be important 
to compare the impact of multiple clock gene mutations, in 
particular metabolic phenotypes, to distinguish between 
gene-specific effects and the more general effects on 
specific processes of disrupting the clock network. Soon, 
studies exploiting both conditional rescue and ablation 
approaches will provide opportunities to dissect the cell-
autonomous and multitissue role of the clock gene network 
in metabolic physiology (Hong et al., 2007; McDearmon et 
al., 2006). Analysis of biological oscillations produced by the 
clock network provides an ideal model for complex systems 
biology. A full understanding of the dynamic function of the 
circadian network will require integration of genetic, cellular, 
and physiological analyses.
Mutations and the Circadian/Metabolic Systems
Mutations that affect the functions of the circadian system 
have a broad impact on metabolic function, but the reverse is 
also true. Mutations or challenges that cause metabolic prob-
lems also have been shown to affect the circadian system. 
Recent studies in high-fat-fed animals have shown that intro-
duction of calorically dense chow leads to rapid changes in 
both the period of locomotor activity in constant darkness and 
to increased food intake during the normal rest period under 
Figure 5. Neural Pathways Linking Circadian and Metabolic Systems
Neuroanatomical studies have implicated several nodal points that may connect circadian, sleep, and metabolic centers within the brain. External cues such 
as light are transmitted from the eyes via the retinohypothalamic tract (RHT) to the SCN. Projections from the suprachiasmatic nucleus (SCN) extend toward 
the subparaventricular zone (SPZ) and from the SPZ to the dorsomedial hypothalamus (DMH). Also shown are the medial preoptic area (mPOA) and the ven-
trolateral preoptic nucleus (VLPO), two relay regions of the hypothalamus that receive projections from the DMH and SPZ and may integrate circadian and 
wakefulness signals. Clock gene expression has been identified in DMH neurons, and the DMH has emerged as an important site in the activity response to food 
(the food-entrainable oscillator). The DMH has many outputs to other regions of the brain, including the lateral hypothalamus (LHA), which controls circadian 
regulation of the sleep/wakefulness and fasting/feeding cycles. Inset: The LHA also receives neuroendocrine input from the arcuate (ARC) neurons producing 
anorexigenic and orexigenic neuropeptides.The hormone leptin produced by adipose tissue activates the production of anorexigenic neuropeptides such as 
αMSH/CART, which in turn blocks production of the orexigenic peptides orexin (ORX) and melanin-concentrating hormone (MCH) in the LHA. In the absence of 
leptin, orexigenic neurons in the ARC produce the neuropeptide NPY/AgRP that stimulates hunger and decreased energy expenditure via signaling to the LHA. 
In addition to insulin, ghrelin, and other incretins may also influence circadian behavioral rhythms through direct effects on SCN or indirectly through actions 
within other regions of midbrain and brainstem. Arrows in inset indicate functional links.12 hr light/12 hr dark conditions (Kohsaka et al., 2007). These 
changes in behavioral rhythmicity corresponded with altered 
clock gene expression within peripheral metabolic tissues, and 
as well as with altered cycling of the nuclear hormone receptors 
involved in sterol, lipid, and carbohydrate metabolism in both 
liver and visceral white adipose tissue. One implication of these 
findings is that nutritional status directly affects the phase of 
the SCN clock, as activity in darkness was lengthened. The 
findings also show that peripheral clock gene expression is 
sensitive to exposure to an obesity-inducing environment—a 
condition that is anticipated to reflect more common causes of 
clock dysfunction in humans than primary missense mutations 
in the function of the core clock genes.
In another example, locomotor activity rhythms were affected 
by disruption of the brain-specific Homeobox Factor Bsx, a 
gene encoding a recently identified key regulator of hypotha-
lamic Npy/AgRP neuron development (Sakkou et al., 2007). Bsx 
mutant mice are not only resistant to obesity when crossed with 
leptin-deficient obese (ob) mice; they also display attenuated 
onset and dampened amplitude of nocturnal locomotor activity. 
Determination of the period length of locomotor activity under 
constant conditions in metabolic mutant mice will yield greater 
insight into the role of these signaling pathways in the SCN. 
They will also shed light on extra-SCN clock gene expression 
and function. Furthermore, understanding the effect of these 
important mediators of behavior and energy balance on both 
locomotor activity and sleep will broaden our knowledge of the 
links between circadian and metabolic systems.Brain-Peripheral Tissue Crosstalk and Energy Balance
Identification of the interactions between transcriptional net-
works that control circadian, cell, and metabolic cycles may 
provide a framework to better understand the impact of circa-
dian control not only within individual tissues, but also between 
brain and peripheral tissues that participate in energy storage 
and utilization.
Anatomical and molecular studies have colocalized several 
brain regions in which neural networks involved in circadian 
and metabolic systems overlap (Figure 5). Importantly, clock 
genes have been shown to cycle not only within the SCN, but 
also in several other brain regions. These regions include the 
forebrain in nuclei surrounding the third ventricle, where either 
orexigenic (NPY/AgRP) or anorexigenic (POMC/CART) neuro-
peptides are expressed, and the dorsomedial nucleus, a relay 
site to brainstem regions involved in wakefulness and sleep 
(Elmquist et al., 1998; Gooley et al., 2006; Mieda et al., 2006). 
Hypothalamic neuropeptides, particularly AgRP and POMC, 
are also expressed according to a pronounced diurnal rhythm, 
although the extent to which these oscillations are entrained 
by feeding, light, or nutrient signaling remains uncertain 
(reviewed in Kalra et al., 1999). Infusion of intralipid (an aque-
ous lipid emulsion), which induces elevation of circulating free 
fatty acids, has been shown to acutely modulate expression 
of orexin. The activity of orexin neurons has also been tied to 
glucose metabolism and leptin (Chang et al., 2004; Date et al., 
1999; Yamanaka et al., 2003). Interestingly, recent studies in 
dogs fed high-fat diets suggest that nocturnal elevation (dur-Cell 134, September 5, 2008 ©2008 Elsevier Inc. 735
ing sleep) of free fatty acids may be an early hallmark of the 
insulin-resistant state (Kim et al., 2007). Taken together, both 
nutrients and the hormonal signals tied to nutrient balance are 
likely to impact regions of the hypothalamus important in con-
trol of circadian systems, wakefulness, and sleep.
Curiously, projections from the master pacemaker neurons of 
the SCN also synapse on the subparaventricular zone, a region 
that in turn projects to the lateral hypothalamic area (LHA) 
neurons that express hypocretin/orexin, indicating presence 
of a “hardwired” circuit joining centers involved in rhythmicity, 
wakefulness, and feeding (Horvath and Gao, 2005). Projections 
from forebrain regions also reach both the midbrain and the 
hindbrain to nuclei implicated in dopaminergic-reward aspects 
of feeding and in cholinergic- and incretin-mediated satiety 
signaling (Abizaid et al., 2006; Drucker, 2006; Farooqi et al., 
2007; Fulton et al., 2006; Hagan et al., 2000; Harris et al., 2005; 
Williams et al., 2006). In Clock mutant mice, altered expression 
of hypothalamic neuropeptides within leptin-responsive neu-
rons of the arcuate nucleus correlates with the development 
of hyperphagia and obesity. Both the temporal pattern and 
absolute expression levels of orexin and hypothalamic ghrelin 
are diminished in these animals (Turek et al., 2005). Moreover, 
Clock mutant animals display alterations in both hedonic drive 
(cocaine response) and cholinergic signaling (autonomic tone), 
suggesting additional neural effects of the clock network that 
may impact body weight and fuel utilization (Curtis et al., 2007; 
McClung et al., 2005; Reilly et al., 2007). A major goal now will 
be to unravel the role of clock gene expression within forebrain, 
midbrain, and hindbrain. It will be crucial to test the effect of 
clock gene function within neuronal subpopulations that may 
be important in the spectrum of metabolic and behavioral 
abnormalities that arise in mice harboring disrupted circadian 
cycle genes.
Food Ingestion and Circadian/Metabolic Systems
The prevailing model for understanding long-term body 
weight constancy holds that the tonic or baseline function 
of neurons in the hypothalamic orexigenic and anorexigenic 
centers is dynamically regulated by changes in the levels of 
peripheral hormones (principally leptin and insulin) that are 
produced in relationship to nutrient stores and food avail-
ability. The discovery of leptin was a watershed in yielding 
molecular insight into the pathways linking the peripheral and 
neural systems involved in feeding and energy expenditure. 
Although the major effect of leptin involves maintenance of 
body mass constancy during the challenge of famine, lep-
tin itself is expressed in mice according to a diurnal rhythm 
(with relatively higher levels during the dark period) (Ahima et 
al., 1998). The absence of leptin during periods of food scar-
city results in decreased energy expenditure and quiescent 
neuroendocrine systems, including the thyroidal and repro-
ductive axes (Ahima and Flier, 2000). More recently, studies 
on hypothalamic nutrient sensing have uncovered an impor-
tant role of hypothalamic leptin and nutrient signaling in the 
regulation of peripheral gluconeogenesis, a process that is 
particularly important during sleep, when the liver serves as 
the major source of glucose (Parton et al., 2007; Pocai et al., 
2005; Sandoval et al., 2007).736 Cell 134, September 5, 2008 ©2008 Elsevier Inc.Interestingly, although both leptin and melanocortinergic 
signaling mediate hypothalamic regulation of feeding, energy 
utilization, and glucose metabolism, the specific hypothalamic 
neurons involved in the control of gluconeogenesis appear to 
be distinct from those involved in energy expenditure. This 
suggests a sort of specialization within the neural energy cir-
cuit itself (Claret et al., 2007; Parton et al., 2007). With regard 
to hypothalamic control of the liver, it has also been demon-
strated that mammalian glucose metabolism is subjected to 
pronounced diurnal variation across the light-dark cycle, with 
alternating cycles of gluconeogenesis and glycogen synthesis 
that are coordinated with the rest-activity cycle (reviewed in 
Ramsey et al., 2007). Temporal control of hypothalamic auto-
nomic efferents to liver, fat, and possibly pancreas may play a 
role in human glucose constancy. Interestingly, in fibroblasts, 
activation of 5′-AMP-activated kinase (AMPK), an important 
nutrient sensor in the liver, led to a phase advance in clock pro-
tein expression. Activation of AMPK also correlated with phase 
advances in mice after treatment with metformin, an antihy-
perglycemic biguanide that is thought to target AMPK (Um et 
al., 2007). Clearly, it will be important to further examine the 
effects of the AMPK pathway on both peripheral interactions 
between circadian and metabolic pathways. AMPK signaling 
should also be assessed at the level of hypothalamic neurons, 
where AMPK has been implicated in feeding regulation (Martin 
et al., 2006).
In addition to evidence for interactions between circadian 
and metabolic systems at the level of adiposity hormones, 
the discovery of gut-derived polypeptides involved in control 
of meal size, meal timing, gastric emptying, and endocrine 
pancreas function provides an additional window into links 
between circadian and metabolic systems (Drucker, 2006; 
Murphy and Bloom, 2006; Nyholm et al., 1999). As mentioned 
above, studies with ghrelin have indicated effects on both SCN 
oscillators and locomotor activity patterns in mice, though the 
effects were dependent upon the nutritional state of the animal 
(Tang-Christensen et al., 2004; Yannielli et al., 2007). In addi-
tion, studies of gastrin-releasing peptide, a mediator of both 
feeding and locomotor activity, indicate an effect on circadian 
phase that opposes effects of NPY (discussed above) (Gamble 
et al., 2007; Ladenheim et al., 2002). Peptide tyrosine-tyrosine 
(PYY3-36), a gut-derived member of the pancreatic polypeptide 
family, has also been shown to not only influence feeding but 
to also correlate with alterations to wakefulness and sleep 
architecture (Akanmu et al., 2006). A link between circadian 
physiology and responsiveness of endocrine pancreas to the 
incretin hormone glucagon-like peptide-1 has also been sug-
gested in studies showing direct effects of melatonin on pan-
creatic β cells (Kemp et al., 2002). Studies of gastrointestinal 
clock gene expression in rodents have established expression 
of clock components within both stomach and colon, although 
clock function within the small intestine (specifically within 
cells that express anorectic and insulinotropic polypeptides) 
remains to be examined (Hoogerwerf et al., 2007). Nonethe-
less, the observation of clock gene expression within the colon 
is significant with regards to circadian control of incretin pro-
duction, as there is abundant expression of PYY3-36 and related 
neuroendocrine polypeptides in the distal colon.
Figure 6. Circadian Synchrony and Meta-
bolic Disease
Many aspects of metabolic physiology are known 
to occur at specific times each day. Gene expres-
sion patterns corresponding to periods of energy 
storage and energy utilization have been tied to 
the function of the peripheral clock in the liver and 
are shown as outputs of the clock (the cycle of 
energy storage and utilization). Many disorders 
such as myocardial infarction peak at certain times 
during a 24 hr day, suggesting a potential link be-
tween disruption of circadian rhythms and dis-
ease pathology. Emerging evidence suggests that 
disruption of synchrony between periods of rest/
activity with feeding/fasting and energy storage/
utilization may be tied to dysregulation of not only 
body weight but also diverse metabolic processes 
such as glucose metabolism, vascular reactivity, 
thrombosis, and lipid homeostasis.Circadian Disruption and Metabolic Disease
At the clinical and epidemiologic level, several lines of evidence 
suggest that circadian disruption is associated with cardiovas-
cular and metabolic complications across large segments of 
the human population (reviewed in Laposky et al., 2007) (Figure 
6). Cross-sectional studies have uncovered an increased prev-
alence of metabolic syndrome, high body mass index (BMI), 
and cardiovascular events in shift workers (Ellingsen et al., 
2007; Karlsson et al., 2001). These observations raise the pos-
sibility that chronic misalignment between the cycles of rest 
and activity, and those of fasting and feeding, may contribute 
to the initiation and progression of obesity and metabolic syn-
drome. With regard to feeding, intriguing behavioral studies in 
humans suggest that nocturnal feeding patterns (“night-eating 
syndrome”) may represent an independent risk for metabolic 
disease (Allison et al., 2007). These findings are reminiscent 
of recent experimental rodent studies showing that excess 
energy intake during diet-induced obesity leads to increased 
energy intake only during the rest period and not during the 
active period when the animal normally eats (Kohsaka et al., 
2007). Thus, it appears that the capacity to defend long-term 
energy constancy is related both to the time of day when food 
is consumed and to the relationship between meal (or snack) 
time and the sleep-wake cycle.
How might circadian misalignment impact the metabolic 
comorbidities of obesity, diabetes, and cardiovascular dis-
ease? Several lines of evidence suggest that circadian dysreg-
ulation may exert a broad impact not only on glucose control 
but also on inflammation, fibrinolysis, fluid balance, and vas-
cular reactivity. Indeed, circadian control of glucose metabo-
lism in humans is a well-recognized aspect of clinical diabetes 
management, and an alteration in the normal cyclic pattern of 
glucose tolerance is a hallmark of type 2 diabetes (Holterhus 
et al., 2007). This phenomenon of circadian control of glucose 
metabolism is perhaps most familiar to individuals with type 1 
diabetes mellitus. These patients must adjust their daily insulin 
requirements around the light-dark cycle according to fluctua-
tions in the basal requirement for insulin, as well as in response 
to changes in glycemic excursion after meals in the morning and at night (Van Cauter et al., 1997). Consideration of the 
physiological and molecular basis for changes in the circadian 
pattern of glucose tolerance, and for variation in the counter-
regulatory response to hypoglycemia, may ultimately lead to 
better strategies for diabetes management.
In addition to control of glucose metabolism, circadian sys-
tems may also participate in additional components of the 
metabolic syndrome. A central node linking metabolic and cir-
cadian pathways involves the nuclear receptor superfamily, as 
reviewed above. The pathways regulated include those down-
stream of Rev-ERBα and the RORs that modulate the core 
clock and diverse metabolic processes ranging from adipo-
genesis to inflammation and thrombosis (reviewed in Duez and 
Staels, 2008). Indeed, PAI-1, an important component of the 
fibrinolytic cascade that signals the breakdown of coagulation 
products, is subjected to circadian control and is a downstream 
target of Rev-erbα and RORα. Further studies are needed to 
address whether the strong clustering of acute cardiovascular 
catastrophes within restricted times of the day may be related 
to disruptions in normal circadian regulation of these pathways 
within liver, adipose tissue, or perhaps the vasculature.
In experimental animal models, repeated misalignment of 
internal phase with the light cycle, a so-called “jet lag” para-
digm, has also been associated with accelerated cardiomyo-
pathy and premature mortality (Davidson et al., 2006; Penev et 
al., 1998). Both epidemiologic and clinical studies have begun 
to probe whether restricted sleep, or altered cycling of sleep-
wakefulness states, may contribute to hyperphagia and met-
abolic dysregulation. Reduced sleep time is associated with 
increased BMI, and forced sleep restriction in humans is tied to 
alterations of neuroendocrine control of appetite and glucose 
tolerance (Spiegel et al., 2004; Taheri et al., 2004; Tasali et al., 
2008).
Although previous work has focused on the impact of sleep 
loss on cognitive and mood disorders, further investigation 
is needed to examine the link between altered circadian syn-
chrony and human health. To achieve this goal, it will be neces-
sary to establish standard methodologies for the analysis of 
circadian parameters in studies of feeding and glucose metab-Cell 134, September 5, 2008 ©2008 Elsevier Inc. 737
olism in human subjects. Furthermore, experimental genetic 
strategies need to be applied in animal models to pinpoint the 
underlying pathways important in coordinating these systems. 
The availability of temporal and metabolic phenotype data in 
humans will ultimately enable association studies to evaluate 
the contribution of circadian gene variation to human diabetes 
and obesity. Biological oscillations represent an area of meta-
bolic physiology that, although familiar to most of us, is often 
overlooked in both clinical trial design and in experimental 
genetic studies. It seems opportune to consider timing and the 
clock system as we search for new mechanism-based treat-
ments for metabolic disease.
Future Perspectives
The past decade has witnessed major strides in our under-
standing of the neurobehavioral basis of both feeding and 
circadian timing. Interestingly, both circadian and metabolic 
systems involve extensive crosstalk between CNS and periph-
eral tissues through humoral, nutrient, and direct neural wir-
ing. At the organismal level, physiologic observations suggest 
that the circadian clock may be important in a wide range 
of pathologies that cluster at specific times of day, including 
myocardial infarction, arrhythmogenicity, congestive heart 
failure, thrombosis, and carbohydrate and lipid turnover. Yet, 
we still have little knowledge of the identities of the internal 
environmental sensors that couple circadian systems with 
processes ranging from nutrient homeostasis to coagulation, 
cytokine production, respiration, and myocardial contractil-
ity. In addition, circadian clock proteins, such as CLOCK and 
BMAL1, may also have functions independent of their roles as 
components of the circadian oscillator. Thus, both inter- and 
intraorgan asynchrony may also contribute to chronic pathol-
ogies such as diabetes, obesity, and cardiovascular disease. 
Current gaps in our understanding of the circadian system 
include the contributions of CNS oscillators versus periph-
eral oscillators for regulating circadian homeostasis and the 
detailed mechanisms by which peripheral organ clocks mod-
ulate tissue physiology. Studies of the circadian clock have 
opened a window on the molecular control of behavior, and 
now open a unique opportunity to probe the molecular links 
between behavior and metabolism.
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